美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

DAMORA THERAPEUT

24.94

-3.4550-12.17%

成交量：108.13萬

成交額：2,761.13萬

市值：15.35億

市盈率：-2.52

高：28.17

開：28.12

低：24.75

收：28.39

52周最高：38.33

52周最低：2.72

股本：6,155.32萬

流通股本：4,764.87萬

量比：2.58

換手率：2.27%

股息：- -

股息率：- -

每股收益(TTM):-9.8764

每股收益(LYR):-153.9532

淨資產收益率：-99.74%

總資產收益率：-21.61%

市淨率：3.98

市盈率(LYR):-0.16

資料載入中...

總覽公司新聞資訊公告

Damora Therapeutics啓動Dmr-001治療突變CALR驅動型原發性血小板增多症與骨髓纖維化的Clarity-101 1/1B期臨床試驗

美國研究綜述-黑石集團、哈特福德保險公司、澤夫拉治療公司

傑富瑞首次覆蓋Damora Therapeutics，給予買入評級，目標價50美元

美國研究綜述-思科、DTE能源、美滿科技

Galecto Inc旗下Damora計劃於2026年中提交DMR-001新藥臨床試驗申請概念驗證數據預計2027年中公布

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/DMRA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMRA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","market":"US","secType":"STK","nameCN":"DAMORA THERAPEUT","latestPrice":24.935,"timestamp":1789497882027,"preClose":28.39,"halted":0,"volume":1081337,"delay":0,"changeRate":-0.12169778090877076,"floatShares":47648701,"shares":61553200,"eps":-9.876431,"marketStatus":"交易中","change":-3.455,"latestTime":"09-15 14:44:43 EDT","open":28.12,"high":28.165,"low":24.75,"amount":27611263.378038,"amplitude":0.120289,"askPrice":24.98,"askSize":205,"bidPrice":24.89,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-9.876431,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":2,"adr":0,"listingDate":1603944000000,"exchange":"NASDAQ","adjPreClose":28.39,"preHourTrading":{"tag":"盘前","latestPrice":28,"preClose":28.39,"latestTime":"09:28 EDT","volume":158,"amount":4442.999974,"timestamp":1789478886049,"change":-0.39,"changeRate":-0.013737,"amplitude":0.033462},"postHourTrading":{"tag":"盘后","latestPrice":28.39,"preClose":28.39,"latestTime":"19:30 EDT","volume":13529,"amount":384126.03,"timestamp":1789428601108,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.577267},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMRA\",,,,,undefined,":{"symbol":"DMRA","floatShares":47648701,"roa":"-21.61%","roe":"-99.74%","lyrEps":-153.953213,"volumeRatio":2.577267,"shares":61553200,"dividePrice":0,"high":28.165,"amplitude":0.120289,"preClose":28.39,"low":24.75,"week52Low":2.724,"pbRate":"3.98","week52High":38.3251,"institutionHeld":0,"latestPrice":24.935,"committee":-0.344262,"eps":-9.876431,"divideRate":0,"volume":1081337,"delay":0,"ttmEps":-9.876431,"open":28.12,"prevYearClose":23.01,"prevWeekClose":28.1,"prevMonthClose":28.18,"prevQuarterClose":26.01,"fiveDayClose":29.17,"twentyDayClose":31.09,"sixtyDayClose":21.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMRA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-12","symbol":"DMRA","fiscalQuarterEnding":"2026/03","expectedEps":-0.21,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.62},{"market":"US","date":"2026-03-19","symbol":"DMRA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1773892800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-06","symbol":"DMRA","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-2.36},{"market":"US","date":"2025-08-05","symbol":"DMRA","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-2.6},{"market":"US","date":"2025-05-08","symbol":"DMRA","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"post","actualEps":-1.92}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMRA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMRA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":10,"updateTime":1785297600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMRA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMRA","date":"2026-09-14","current":-2.541404,"percent":0.748031,"low":-100.260711,"twenty":-7.705702,"median":-7.184629,"eighty":-6.354091,"high":-5.207587,"avg":-12.294626,"sd":20.772963,"marketCap":1734768083},"quantilePoints":[{"date":"2026-03-13","current":-100.260711,"twenty":-100.260711,"median":-100.260711,"eighty":-98.29884,"marketCap":1588530698},{"date":"2026-03-20","current":-72.999835,"twenty":-100.199878,"median":-95.983376,"eighty":-84.763454,"marketCap":1156609382},{"date":"2026-03-27","current":-7.36551,"twenty":-98.861547,"median":-80.41388,"eighty":-7.003988,"marketCap":1545571323},{"date":"2026-04-02","current":-7.207452,"twenty":-96.587906,"median":-7.443103,"eighty":-7.019507,"marketCap":1512404556},{"date":"2026-04-10","current":-7.670132,"twenty":-94.238224,"median":-7.361199,"eighty":-7.021806,"marketCap":1609492728},{"date":"2026-04-17","current":-7.759219,"twenty":-89.113027,"median":-7.443103,"eighty":-7.088477,"marketCap":1628186724},{"date":"2026-04-24","current":-7.305161,"twenty":-78.931071,"median":-7.519258,"eighty":-7.200555,"marketCap":1532907649},{"date":"2026-05-01","current":-7.374132,"twenty":-59.951712,"median":-7.420112,"eighty":-7.071235,"marketCap":1547380419},{"date":"2026-05-08","current":-7.181588,"twenty":-7.748873,"median":-7.369821,"eighty":-7.098823,"marketCap":1506977267},{"date":"2026-05-15","current":-6.125513,"twenty":-7.702318,"median":-7.328151,"eighty":-6.979849,"marketCap":1440040702},{"date":"2026-05-22","current":-6.376895,"twenty":-7.679328,"median":-7.296539,"eighty":-6.874668,"marketCap":1499137850},{"date":"2026-05-29","current":-6.50384,"twenty":-7.670132,"median":-7.208889,"eighty":-6.624282,"marketCap":1528981338},{"date":"2026-06-05","current":-5.841412,"twenty":-7.647141,"median":-7.181588,"eighty":-6.506459,"marketCap":1373251758},{"date":"2026-06-12","current":-5.592674,"twenty":-7.644267,"median":-7.103996,"eighty":-6.310202,"marketCap":1314776223},{"date":"2026-06-18","current":-5.608384,"twenty":-7.605184,"median":-7.036462,"eighty":-6.158347,"marketCap":1318469415},{"date":"2026-06-26","current":-5.909488,"twenty":-7.595413,"median":-6.974676,"eighty":-5.98699,"marketCap":1389255588},{"date":"2026-07-02","current":-7.092956,"twenty":-7.5092,"median":-6.96318,"eighty":-6.007936,"marketCap":1667476025},{"date":"2026-07-10","current":-8.059107,"twenty":-7.645417,"median":-7.006288,"eighty":-6.078901,"marketCap":1894607311},{"date":"2026-07-17","current":-7.917719,"twenty":-7.67473,"median":-7.092956,"eighty":-6.150138,"marketCap":1861368586},{"date":"2026-07-24","current":-7.637561,"twenty":-7.776537,"median":-7.12986,"eighty":-6.183485,"marketCap":1795506668},{"date":"2026-07-31","current":-7.648035,"twenty":-7.738833,"median":-7.190209,"eighty":-6.195797,"marketCap":1797968796},{"date":"2026-08-07","current":-7.82346,"twenty":-7.815082,"median":-7.208161,"eighty":-6.219919,"marketCap":1839209436},{"date":"2026-08-14","current":-7.218207,"twenty":-7.815082,"median":-7.209243,"eighty":-6.276357,"marketCap":1897132498},{"date":"2026-08-21","current":-7.119553,"twenty":-7.785196,"median":-7.218207,"eighty":-6.321676,"marketCap":1871203580},{"date":"2026-08-28","current":-7.187671,"twenty":-7.738833,"median":-7.209243,"eighty":-6.354091,"marketCap":1889106881},{"date":"2026-09-04","current":-6.576954,"twenty":-7.707949,"median":-7.198831,"eighty":-6.380999,"marketCap":1728594532},{"date":"2026-09-11","current":-6.30448,"twenty":-7.706597,"median":-7.187671,"eighty":-6.346489,"marketCap":1656981329},{"date":"2026-09-14","current":-6.600443,"twenty":-7.705702,"median":-7.184629,"eighty":-6.354091,"marketCap":1734768083}],"updateTime":1789486782356},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DMRA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1112635870","title":"Damora Therapeutics啓動Dmr-001治療突變CALR驅動型原發性血小板增多症與骨髓纖維化的Clarity-101 1/1B期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1112635870","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112635870?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 20:01","pubTimestamp":1785931269,"startTime":"0","endTime":"0","summary":"Damora Therapeutics正式启动一项名为Clarity-101的1/1B期临床试验，旨在评估其候选药物Dmr-001在突变型钙网蛋白驱动的原发性血小板增多症及骨髓纤维化患者中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654901371","title":"美國研究綜述-黑石集團、哈特福德保險公司、澤夫拉治療公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2654901371","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654901371?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 16:57","pubTimestamp":1785142662,"startTime":"0","endTime":"0","summary":"美国研究综述-黑石集团、哈特福德保险公司、泽夫拉治疗公司路透7月27日-周一，华尔街证券分析师下调了对包括黑石集团、哈特福德保险公司和泽夫拉治疗公司等数家在美国上市企业的评级和目标股价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL4T43T0KH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BANR","CEG","BAH","BAX","BX","FHB","HWM","CLF","FTNT","JRE","FTAI","PRVT","FLG","FISI","CELC","ITA","CDRE","AAPD","FCNCA","AGIO","CYH","DMRA","SRCE","AAPY","AAPL","CRED","CATY","CUBI","AMAL","EBC","HIG","BBRE","BWXT","DLR","FMBH","GM","BAM","HON","F","FVCB","BY","ARLO","CHTR","CPF","AAL","FRBA","IXN","AXP","UTES","XAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105165649","title":"傑富瑞首次覆蓋Damora Therapeutics，給予買入評級，目標價50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105165649","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105165649?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 14:03","pubTimestamp":1785132188,"startTime":"0","endTime":"0","summary":"杰富瑞（Jefferies）近日对Damora Therapeutics（重组前）启动覆盖研究，给予其“买入”评级，并将目标股价设定为50美元。这一举措凸显了市场对该公司发展前景的乐观预期，分析师认为其具备显著的成长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635995937","title":"美國研究綜述-思科、DTE能源、美滿科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2635995937","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635995937?lang=zh_tw&edition=fundamental","pubTime":"2026-05-14 15:25","pubTimestamp":1778743532,"startTime":"0","endTime":"0","summary":"美国研究综述-思科、DTE能源、美满科技路透5月14日 - 周四，华尔街证券分析师调整了多家在美国上市公司的评级和目标股价，其中包括思科、DTE能源和美满科技。股票条目按字母顺序排列。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL4S41R0NW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEE","DMRA","MAIN","LU0444971666.USD","TXRH","CSCO","DT","CSCS","IE00BSNM7G36.USD","LU1244550221.USD","TNGX","GSHD","ARMK","EYE","STAA","LU0868494708.USD","LU0234570918.USD","USFD","CMS","AMGN","VSH","CAKE","WY","WEC","LU1074936037.SGD","MOH","BK4606","LU1093756168.USD","CSCL","MRVL","ARVN","LU1084165304.USD","LU0054578231.USD","LU2023251221.USD","MRVU","USPH","NHI","XEL","DOCS","HLIO","JACK","KRMN","MIRM","CMP","IE00BFTCPJ56.SGD","LU0661504455.SGD","DTE","MVLL","ABBV","LU1989764748.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151744301","title":"Galecto Inc旗下Damora計劃於2026年中提交DMR-001新藥臨床試驗申請 概念驗證數據預計2027年中公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1151744301","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151744301?lang=zh_tw&edition=fundamental","pubTime":"2026-03-09 20:07","pubTimestamp":1773058034,"startTime":"0","endTime":"0","summary":"生物技术公司Galecto Inc.近日披露其子公司Damora的最新研发进展。根据规划，Damora拟于2026年中期向监管机构提交DMR-001的新药临床试验申请或临床试验授权，该时间表标志着其在纤维化疾病治疗领域的重要里程碑。与此同时，针对DMR-001的概念验证关键数据集预计将在2027年中期揭晓。此次进展凸显了Galecto Inc.通过Damora平台深化其在创新疗法领域的战略布局。若后续研究顺利推进，DMR-001有望为特定纤维化疾病患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DMRA","GLTO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}